Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 9/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butyric Acid SCHEMBL144703 | 0.87 | BBOX1 (0.55) | BBOX1ALDH1A1TSHR | |
| Propionic Acid SCHEMBL145939 | 0.85 | BBOX1 (0.50) | BBOX1ALDH1A1TSHRTHRBKMT2A | |
| Valeric Acid SCHEMBL145154 | 0.84 | BBOX1 (0.61) | BBOX1KMT2AHTTDNM1 | |
| Propionic Acid SCHEMBL144975 | 0.84 | CHRM5 (0.43) | ALDH1A1TSHRKMT2AMEN1CYP2C19 | |
| Hexanoate SCHEMBL2762435 | 0.83 | BBOX1 (0.59) | BBOX1KMT2AHTTDNM1 | |
| SCHEMBL202691 | 0.83 | DNM1 (0.40) | BBOX1ALDH1A1TSHRKMT2AESR1 | |
| Propionic Acid SCHEMBL142973 | 0.82 | ALDH1A1 (0.38) | BBOX1ALDH1A1TSHRTHRB | |
| Propionic Acid SCHEMBL142732 | 0.82 | BBOX1 (0.52) | BBOX1KMT2AMEN1CYP2C19RECQL | |
| Dodecanoate SCHEMBL2761983 | 0.82 | BBOX1 (0.57) | BBOX1KMT2AHTTDNM1 | |
| Heptanoate SCHEMBL2762022 | 0.82 | BBOX1 (0.57) | BBOX1KMT2AHTTDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120058057-A1 | Anti-dandruff Agents | MERCK PATENT GMBH (DE) | 2012-03-08 | — | — | US | claimed |
| WO-2010136104-A2 | ANTI-DANDRUFF AGENTS | MERCK PATENT GMBH (DE) | 2010-12-02 | — | — | WO | claimed |
| US-20120058057-A1 | Anti-dandruff Agents | MERCK PATENT GMBH (DE) | 2012-03-08 | — | — | US | disclosed |
| WO-2010136104-A2 | ANTI-DANDRUFF AGENTS | MERCK PATENT GMBH (DE) | 2010-12-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120058057-A1 | Anti-dandruff Agents | POLR1C, ETF1, PIK3C3 | BBOX1 416/4885ALDH1A1 272/4885TSHR 4265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.